Seagen
SGEN
#564
Rank
A$61.48 B
Marketcap
A$325.89
Share price
-0.07%
Change (1 day)
47.87%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -A$1.2 Billion

According to Seagen 's latest financial reports the company's current earnings are A$2.30 Billion. In 2022 the company made an earning of -A$0.88 Billion, an increase over its 2021 earnings that were of -A$0.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$1.2 Billion36.6%
2022 -A$0.88 Billion-10.13%
2021 -A$0.98 Billion-214.28%
2020 A$0.85 B-370.63%
2019 -A$0.32 Billion-15.17%
2018 -A$0.38 Billion32.79%
2017 -A$0.28 Billion37.19%
2016 -A$0.21 Billion18%
2015 -A$0.18 Billion56.34%
2014 -A$0.12 Billion23.07%
2013 -A$89.56 Million
2011 -A$0.21 Billion111.72%
2010 -A$97.17 Million-19.63%
2009 -A$0.13 Billion-7.55%
2008 -A$0.14 Billion64.95%
2007 -A$79.28 Million38.4%
2006 -A$57.29 Million25.36%
2005 -A$45.7 Million-14.86%
2004 -A$53.67 Million61.92%
2003 -A$33.15 Million-7.67%
2002 -A$35.9 Million6.76%
2001 -A$33.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$16.88 B-1,599.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.36 B-309.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.71 B-340.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.44 B-1,116.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.28 B-1,279.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$88.17 Million-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-A$89.45 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.37 Billion-67.59%๐Ÿ‡บ๐Ÿ‡ธ USA